LncRNA GAS6-AS1 Facilitates Tumorigenesis and Metastasis of Colorectal Cancer by Regulating TRIM14 Through MiR-370-3p/miR-1296-5p and FUS

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2022 Aug 12

PMID 35962353

Authors

Qing Chen

Lin Zhou

De Ma

Juan Hou

Yuxin Lin

Jie Wu

Min Tao

Affiliations

Soon will be listed here.

Abstract

Background: Long non-coding RNAs (lncRNAs) are essential regulators of tumorigenesis and the development of colorectal cancer (CRC). Here, we aimed to investigate the role of lncRNA GAS6-AS1 in CRC and its potential mechanisms.

Methods: Bioinformatics analyses evaluated the level of GAS6-AS1 in colon cancer, its correlation with clinicopathological factors, survival curve and diagnostic value. qRT-PCR were performed to detect the GAS6-AS1 level in CRC samples and cell lines. The CCK8, EdU, scratch healing, transwell assays and animal experiments were conducted to investigate the function of GAS6-AS1 in CRC. RNA immunoprecipitation (RIP) and dual-luciferase reporter gene analyses were carried out to reveal interaction between GAS6-AS1, TRIM14, FUS, and miR-370-3p/miR-1296-5p.

Results: GAS6-AS1 was greatly elevated in CRC and positively associated with unfavorable prognosis of CRC patients. Functionally, GAS6-AS1 positively regulates CRC proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) in vitro and induces CRC growth and metastasis in vivo. Moreover, GAS6-AS1 exerted oncogenic function by competitively binding to miR-370-3p and miR-1296-5p, thereby upregulating TRIM14. Furthermore, we verified that GAS6-AS1 and TRIM14 both interact with FUS and that GAS6-AS1 stabilized TRIM14 mRNA by recruiting FUS. Besides, rescue experiments furtherly demonstrated that GAS6-AS1 facilitate progression of CRC by regulating TRIM14.

Conclusion: Collectively, these findings demonstrate that GAS6-AS1 promotes TRIM14-mediated cell proliferation, migration, invasion, and EMT of CRC via ceRNA network and FUS-dependent manner, suggesting that GAS6-AS1 could be utilized as a novel biomarker and therapeutic target for CRC.

Citing Articles

Emerging discoveries on the role of TRIM14: from diseases to immune regulation.

Li X, Zhou F, Niu K, Wang Y, Shi Y, Li Y Cell Death Discov. 2024; 10(1):513.

PMID: 39719450 PMC: 11668870. DOI: 10.1038/s41420-024-02276-w.

Human umbilical cord mesenchymal stem cells small extracellular vesicles-derived miR-370-3p inhibits cervical precancerous lesions by targeting DHCR24.

Li W, Zhang C, Gao T, Sun Y, Yang H, Liu L Stem Cells Transl Med. 2024; 14(1).

PMID: 39552565 PMC: 11825698. DOI: 10.1093/stcltm/szae087.

The lncRNA TPTEP1 suppresses PI3K/AKT signalling and inhibits ovarian cancer progression by interacting with PTBP1.

Feng Y, Zhang Z, Yang H, Miao F, Li Y, Zhang M J Cell Mol Med. 2024; 28(20):e70106.

PMID: 39422584 PMC: 11488117. DOI: 10.1111/jcmm.70106.

Enhancing diabetic foot ulcer healing: Impact of the regulation of the FUS and ILF2 RNA‑binding proteins through negative pressure wound therapy.

Tang Y, Ji H, Yan Y, Hu D, Xu M, Xu M Int J Mol Med. 2024; 54(5).

PMID: 39301661 PMC: 11414528. DOI: 10.3892/ijmm.2024.5427.

Long non‑coding RNAs as diagnostic and prognostic biomarkers for colorectal cancer (Review).

Lin Y, Zhao W, Pu R, Lv Z, Xie H, Li Y Oncol Lett. 2024; 28(4):486.

PMID: 39185489 PMC: 11342420. DOI: 10.3892/ol.2024.14619.

References

Yu X, Zhao J, He Y . Long non-coding RNA PVT1 functions as an oncogene in human colon cancer through miR-30d-5p/RUNX2 axis. J BUON. 2018; 23(1):48-54. View

Peng Z, Wu T, Li Y, Xu Z, Zhang S, Liu B . MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting β-catenin. Brain Res. 2016; 1644:53-61. DOI: 10.1016/j.brainres.2016.04.066. View

Wang X, Lu J, Lin Y, Gao C, Qi F . Functional role of long non-coding RNA CASC19/miR-140-5p/CEMIP axis in colorectal cancer progression . World J Gastroenterol. 2019; 25(14):1697-1714. PMC: 6465939. DOI: 10.3748/wjg.v25.i14.1697. View

Liang C, Zhao T, Li H, He F, Zhao X, Zhang Y . Long Non-coding RNA ITIH4-AS1 Accelerates the Proliferation and Metastasis of Colorectal Cancer by Activating JAK/STAT3 Signaling. Mol Ther Nucleic Acids. 2019; 18:183-193. PMC: 6796638. DOI: 10.1016/j.omtn.2019.08.009. View

Chai J, Guo D, Ma W, Han D, Dong W, Guo H . A feedback loop consisting of RUNX2/LncRNA-PVT1/miR-455 is involved in the progression of colorectal cancer. Am J Cancer Res. 2018; 8(3):538-550. PMC: 5883102. View

Xu G, Guo Y, Xu D, Wang Y, Shen Y, Wang F . TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway. Sci Rep. 2017; 7:42411. PMC: 5311867. DOI: 10.1038/srep42411. View

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell. 2011; 146(3):353-8. PMC: 3235919. DOI: 10.1016/j.cell.2011.07.014. View

Wang S, Chen Y, Li C, Wu Y, Guo L, Peng C . TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A protein. Sci Rep. 2016; 6:32336. PMC: 5006124. DOI: 10.1038/srep32336. View

Dong B, Zhang W . High Levels of TRIM14 Are Associated with Poor Prognosis in Hepatocellular Carcinoma. Oncol Res Treat. 2018; 41(3):129-134. DOI: 10.1159/000485625. View

10.

Xiao F, Ouyang B, Zou J, Yang Y, Yi L, Yan H . Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway. Drug Dev Res. 2020; 81(5):544-550. DOI: 10.1002/ddr.21650. View

11.

Zhang P, Dong Q, Zhu H, Li S, Shi L, Chen X . Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression. Gene. 2019; 696:1-9. DOI: 10.1016/j.gene.2018.12.079. View

12.

Cui J, Xu X, Li Y, Hu X, Xie Y, Tan J . TRIM14 expression is regulated by IRF-1 and IRF-2. FEBS Open Bio. 2019; 9(8):1413-1420. PMC: 6668374. DOI: 10.1002/2211-5463.12682. View

13.

Tam C, Wong J, Tsui S, Zuo T, Chan T, Ng T . LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years. Appl Microbiol Biotechnol. 2019; 103(12):4649-4677. DOI: 10.1007/s00253-019-09837-5. View

14.

Shen W, Jin Z, Tong X, Wang H, Zhuang L, Lu X . TRIM14 promotes cell proliferation and inhibits apoptosis by suppressing PTEN in colorectal cancer. Cancer Manag Res. 2019; 11:5725-5735. PMC: 6598940. DOI: 10.2147/CMAR.S210782. View

15.

Jin Z, Li H, Hong X, Ying G, Lu X, Zhuang L . TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1/STAT3 pathway. Cancer Cell Int. 2018; 18:202. PMC: 6288942. DOI: 10.1186/s12935-018-0701-1. View

16.

Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View

17.

Jia Y, Zhao L, Bai H, Zhang C, Dai S, Lv H . The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer. Biosci Rep. 2018; 39(1). PMC: 6328896. DOI: 10.1042/BSR20181556. View

18.

Clark M, Mattick J . Long noncoding RNAs in cell biology. Semin Cell Dev Biol. 2011; 22(4):366-76. DOI: 10.1016/j.semcdb.2011.01.001. View

19.

Zhang G, Chen X, Ma L, Ding R, Zhao L, Ma F . LINC01419 facilitates hepatocellular carcinoma growth and metastasis through targeting EZH2-regulated RECK. Aging (Albany NY). 2020; 12(11):11071-11084. PMC: 7346057. DOI: 10.18632/aging.103321. View

20.

Oh H, Joo Y . Novel biomarkers for the diagnosis and prognosis of colorectal cancer. Intest Res. 2019; 18(2):168-183. PMC: 7206347. DOI: 10.5217/ir.2019.00080. View